1. Home
  2. HBIO vs SNAL Comparison

HBIO vs SNAL Comparison

Compare HBIO & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$6.11

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Logo Snail Inc.

SNAL

Snail Inc.

HOLD

Current Price

$5.19

Market Cap

26.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
SNAL
Founded
1901
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Computer Software: Prepackaged Software
Sector
Industrials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
26.6M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
HBIO
SNAL
Price
$6.11
$5.19
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
12.7K
680.8K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
120.00
EPS
N/A
N/A
Revenue
$116,176,000.00
$81,225,622.00
Revenue This Year
$4.77
$15.53
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.34
52 Week High
$7.50
$5.92

Technical Indicators

Market Signals
Indicator
HBIO
SNAL
Relative Strength Index (RSI) 46.83 84.21
Support Level $5.91 $0.65
Resistance Level $6.70 N/A
Average True Range (ATR) 0.28 0.50
MACD -0.03 0.36
Stochastic Oscillator 9.76 89.42

Price Performance

Historical Comparison
HBIO
SNAL

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

Share on Social Networks: